Suppliers / AOP Orphan Pharmaceuticals

AOP Orphan Pharmaceuticals

Austria Updated 9 July 2026

AOP Orphan Pharmaceuticals is a finished-dose manufacturer based in Austria. It appears in 121 regulatory filings across 13 regulators, without an active US DMF or CEP on file. Its filings concentrate with EMA, MHRA (UK) and AEMPS (ES). Its GMP standing is certified by EMA.

0
active US DMFs
0
valid CEPs
3
registered plants
121
filings across 13 regulators
These figures were checked against the regulators' own files on 25 July 2026
EU GMP
1 of 1 confirmed
Sources: EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
Vienna, United Arab Emirates Not on file
Vienna, Austria Not on file
Vialonga, Portugal Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
EMA 40 1
MHRA (UK) 29 None
AEMPS (ES) 12 None
URPL (PL) 8 None
MPA (SE) 7 None
AIFA (IT) 5 None

Comparing suppliers?

Choose your molecules and target markets. AOP Orphan Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates